Noile-Immune Biotech Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-791	-962	-1,127	-	-
Other Operating Activities	-2	105	-4	-	-
Change in Inventory	6	12	-16	-	-
Change in Accounts Payable	11	-12	-3	-	-
Change in Other Net Operating Assets	24	-30	277	-	-
Operating Cash Flow	-752	-887	-873	-	-
Other Investing Activities	-	-	-5	-	-
Investing Cash Flow	-	-	-5	-	-
Issuance of Common Stock	-	2	2,508	-	-
Other Financing Activities	-	-	-595	-	-
Financing Cash Flow	-	2	1,913	-	-
Miscellaneous Cash Flow Adjustments	-	1	-1	-	-
Net Cash Flow	-752	-884	1,034	-	-
Cash Income Tax Paid	2	2	2	-	-
Levered Free Cash Flow	-453.13	-628.13	-832	-	-
Unlevered Free Cash Flow	-453.13	-628.13	-832	-	-
Change in Working Capital	41	-30	258	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.